Hellenic Telecommunications Organization S.A.
€18.85+€0.28 (+1.51%)
Hellenic Telecommunications Organization S.A.’s quoted price sits in the upper half of its reported 52-week range, 7.96% below the high.
ATH · IATR.AT · EUR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 03:11 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Athens Medical C.S.A.’s quoted price sits in the lower half of its reported 52-week range, 36.99% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Athens Medical C.S.A.’s forward annual dividend is €0.02 per share, paid annual. The forward yield is 1.45% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Athens Medical C.S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Athens Medical C.S.A., together with its affiliated companies, operates and holds ownership of hospital facilities both within Greece and on an international scale. The organization delivers extensive diagnostic and treatment options for various cancers, such as those affecting the breast, gastrointestinal system, blood, liver and pancreas, lungs, prostate, skin, bladder, kidneys, and female reproductive organs. Additionally, it offers advanced robotic surgery, neurosurgical procedures, spinal operations, and therapies for cardiac ailments. Its services encompass a broad range of orthopedic specialties, addressing conditions of the foot and ankle, hand and wrist, hip, knee, shoulder, and spine, in addition to treating sports-related injuries. The company also provides care for chronic conditions including diabetes, endocrine disorders, heart failure, high blood pressure, pain management, respiratory system issues, stroke, and thyroid conditions. Furthermore, Athens Medical C.S.A. runs wellness and preventative health centers and performs cosmetic and reconstructive plastic surgery. The group is also involved in medical education, training, and practical service provision, alongside offering patient care guidance. It currently manages eight hospital units, which collectively feature 1,200 beds. Founded in 1984, Athens Medical C.S.A. is headquartered in Athens, Greece.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:02 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€18.85+€0.28 (+1.51%)
Hellenic Telecommunications Organization S.A.’s quoted price sits in the upper half of its reported 52-week range, 7.96% below the high.
€39.60+€0.24 (+0.61%)
GEK TERNA Holdings, Real Estate, Construction S.A.’s quoted price sits in the upper half of its reported 52-week range, 18.05% below the high.
€13.76+€0.16 (+1.18%)
Athens Water Supply and Sewerage Company S.A.’s quoted price sits in the upper half of its reported 52-week range, 2.27% below the high.
€43.70-€0.40 (-0.91%)
Piraeus Port Authority S.A.’s quoted price sits in the upper half of its reported 52-week range, 10.82% below the high.
€11.00€0.00 (0.0%)
Euronext Athens Holding S.A.’s quoted price sits in the upper half of its reported 52-week range, 8.33% below the high.
€1.54+€0.01 (+0.39%)
Lavipharm S.A.’s quoted price sits in the upper half of its reported 52-week range, 11.72% below the high.
$0.29+$0.01 (+4.5%)
Cosmos Health Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.47% below the high.